Aarti Pharmalabs Ltd Performance
Day's Low
Day's High
₹595.1₹61952 Week's Low
52 Week's High
₹371.1₹721.7
| Returns % | |
| 1 Month Return | -4.16 % |
| 3 Month Return | + 5.49 % |
| 1 Year Return | + 59.65 % |
| Market Stats | |
| Previous Close | ₹609.85 |
| Open | ₹609.85 |
| Volume | 60.88K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹5,526.83Cr |
Aarti Pharmalabs Ltd Key Statistics
| P/E Ratio | 24.53 |
| PEG Ratio | 6.09 |
| Market Cap | ₹5,526.83 Cr |
| P/B Ratio | 2.43 |
| EPS | 23.93 |
| Dividend Yield | 0.69 |
| Sector | Pharmaceuticals |
| ROE | 13.11 |
Aarti Pharmalabs Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹5,526.83 Cr | 22.31% | 0.57 | ₹216 Cr | ₹1,852 Cr | |
| NA | ₹207.23 Cr | 49.33% | 0.79 | ₹7 Cr | ₹339 Cr | |
| NA | ₹10.56 Cr | 219.49% | 0.50 | NA | NA | |
| BUY | ₹6,511.04 Cr | 14.02% | 0.62 | ₹48 Cr | ₹717 Cr | |
| NA | ₹28.64 Cr | 67.38% | 0.50 | NA | NA |
Aarti Pharmalabs Ltd Mutual Fund Holdings
About Aarti Pharmalabs Ltd
Share Price: ₹601.50 per share as on 21 Oct, 2024 04:01 PM
Market Capitalisation: ₹5,526.83Cr as of today
Revenue: ₹555.49Cr as on June 2024 (Q2 24)
Net Profit: ₹55.45Cr as on June 2024 (Q2 24)
Listing date: 30 Jan, 2023
Chairperson Name: Rashesh C Gogri
| Organisation | Aarti Pharmalabs Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Aarti Pharmalabs Ltd
Aarti Pharmalabs Reports Mixed Financial Results - 06 Aug, 2024
Aarti Pharmalabs reported standalone net sales of Rs 393.49 crore for June 2024, up 9.87% YoY. However, net profit decreased by 1.02% to Rs 47.14 crore. EBITDA rose by 5.1% to Rs 85.76 crore. The EPS fell slightly to Rs 5.20. The stock has shown strong performance with 17.70% returns over the last 6 months and 80.88% over the last 12 months.
Aarti Pharmalabs Ltd. Stock Trading at Lower Price with ROCE of 15.38% - 30 Jul, 2024
Aarti Pharmalabs Ltd., a manufacturer of Pharmaceuticals and Nutraceuticals, opened at Rs.595 per share on Tuesday, decreasing around 0.8% as compared to the previous closing price. The stock is trading at a lower price with a P/E ratio of 27.09, which is lower than industry P/E of 36.16. The company reports a Return on Capital Employed (ROCE) of 15.38% and a Return on Equity (ROE) of 12.37%.
Insights on Aarti Pharmalabs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 35.00% to 35.16% in Sep 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 440.78 Cr → 557.71 Cr (in ₹), with an average increase of 7.5% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 7.06% to 7.38% in Sep 2024 quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 4.69% to 4.93% in Sep 2024 quarter
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 65.25 Cr → 55.45 Cr (in ₹), with an average decrease of 15.0% per quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 46.46% to 46.10% in Sep 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, AARTIPHARM stock has moved down by -4.2%
Aarti Pharmalabs Ltd Financials
Index Inclusions
Aarti Pharmalabs Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 46.1% | ||
| Foreign Institutions | 7.38% | 4.48 | |
| Mutual Funds | 4.93% | 5.09 | |
| Retail Investors | 35.16% | 0.46 | |
| Others | 6.43% |
Aarti Pharmalabs Ltd Key Indicators
Aarti Pharmalabs Ltd Valuation
Aarti Pharmalabs Ltd in the last 5 years
Lowest (11.23x)
February 2, 2023
Today (24.53x)
October 18, 2024
Industry (58.10x)
October 18, 2024
Highest (28.14x)
August 29, 2024
Aarti Pharmalabs Ltd Earnings and Dividends
Aarti Pharmalabs Ltd Earnings Results
Aarti Pharmalabs Ltd’s net profit jumped 17.75% since last year same period to ₹55.45Cr in the Q1 2024-2025. On a quarterly growth basis, Aarti Pharmalabs Ltd has generated -15.02% fall in its net profits since last 3-months.
Read More about Earnings ResultsAarti Pharmalabs Ltd Dividends May,2024
In the quarter ending March 2024, Aarti Pharmalabs Ltd has declared dividend of ₹1 - translating a dividend yield of 0.50%.
Read More about Dividends
Aarti Pharmalabs Ltd Technicals Summary
Bearish
Neutral
Bullish
Aarti Pharmalabs Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Aarti Pharmalabs Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Aarti Pharmalabs Ltd shares.
Aarti Pharmalabs Ltd (AARTIPHARM) share price today is ₹601.5
Aarti Pharmalabs Ltd is listed on NSE
Aarti Pharmalabs Ltd is listed on BSE
- Today’s highest price of Aarti Pharmalabs Ltd is ₹619.
- Today’s lowest price of Aarti Pharmalabs Ltd is ₹595.1.
PE Ratio of Aarti Pharmalabs Ltd is 24.53
PE ratio = Aarti Pharmalabs Ltd Market price per share / Aarti Pharmalabs Ltd Earnings per share
Today’s traded volume of Aarti Pharmalabs Ltd(AARTIPHARM) is 60.88K.
Today’s market capitalisation of Aarti Pharmalabs Ltd(AARTIPHARM) is ₹5526.83Cr.
| Aarti Pharmalabs Ltd(AARTIPHARM | Price |
|---|---|
52 Week High | ₹721.7 |
52 Week Low | ₹371.1 |
Aarti Pharmalabs Ltd(AARTIPHARM) share price is ₹601.5. It is down -16.66% from its 52 Week High price of ₹721.7
Aarti Pharmalabs Ltd(AARTIPHARM) share price is ₹601.5. It is up 62.09% from its 52 Week Low price of ₹371.1
| Aarti Pharmalabs Ltd(AARTIPHARM | Returns |
|---|---|
1 Day Returns | -8.35% |
1 Month Returns | -4.16% |
3 Month Returns | 5.49% |
1 Year Returns | 59.65% |